long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
Published 1 year ago • 96 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
8:57
outcomes of sct in t-all and t-lbl
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:06:04
itp: novel treatments
-
6:34
vtct level 2 facial and skin care | our course structure explained
-
2:41
israeli company on the edge of finding diabetes cure
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
0:49
the future of inhibiting bcl2 for the treatment of t-all
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
1:17
phase ii study of tosedostat in mds
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
1:44
insights into the phase ii tidal study
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
0:50
insights into the phase ii window-2 trial
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
1:16
insights into the phase ii smart stop study
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy